In the latest close session, Hims & Hers Health, Inc. (HIMS) was down 3.21% at $31.68. The stock's change was less than the S&P 500's daily loss of 0.14%. At the same time, the Dow lost 0.01%, and the tech-heavy Nasdaq lost 0.57%.
Heading into today, shares of the company had lost 0.7% over the past month, lagging the Medical sector's gain of 5.8% and the S&P 500's gain of 0.25%.
Investors will be eagerly watching for the performance of Hims & Hers Health, Inc. in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on August 10, 2026. In that report, analysts expect Hims & Hers Health, Inc. to post earnings of -$0.07 per share. This would mark a year-over-year decline of 141.18%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $690.21 million, up 26.68% from the year-ago period.
HIMS's full-year Zacks Consensus Estimates are calling for earnings of -$0.27 per share and revenue of $2.91 billion. These results would represent year-over-year changes of -150.94% and +23.78%, respectively.
Investors should also take note of any recent adjustments to analyst estimates for Hims & Hers Health, Inc. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, there's been a 49.21% fall in the Zacks Consensus EPS estimate. Hims & Hers Health, Inc. currently has a Zacks Rank of #3 (Hold).
In terms of valuation, Hims & Hers Health, Inc. is currently trading at a Forward P/E ratio of 1227.38. This signifies a premium in comparison to the average Forward P/E of 27.89 for its industry.
It's also important to note that HIMS currently trades at a PEG ratio of 92.11. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. As of the close of trade yesterday, the Medical Info Systems industry held an average PEG ratio of 2.98.
The Medical Info Systems industry is part of the Medical sector. This group has a Zacks Industry Rank of 74, putting it in the top 31% of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
Beyond Nvidia: AI's Second Wave Is Here
The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.
See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Hims & Hers Health, Inc. (HIMS): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).